Cargando…
Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD
ADHD is a highly prevalent neurodevelopmental disorder. The first-line therapeutic for ADHD, methylphenidate, can cause serious side effects including weight loss, insomnia, and hypertension. Therefore, the development of non-stimulant-based therapeutics has been prioritized. However, many of these...
Autores principales: | Sveinsdóttir, Hildur Sóley, Christensen, Christian, Þorsteinsson, Haraldur, Lavalou, Perrine, Parker, Matthew O., Shkumatava, Alena, Norton, William H. J., Andriambeloson, Emile, Wagner, Stéphanie, Karlsson, Karl Ægir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267219/ https://www.ncbi.nlm.nih.gov/pubmed/36400921 http://dx.doi.org/10.1038/s41386-022-01505-z |
Ejemplares similares
-
adgrl3.1-deficient zebrafish show noradrenaline-mediated externalizing behaviors, and altered expression of externalizing disorder-candidate genes, suggesting functional targets for treatment
por: Fontana, Barbara D., et al.
Publicado: (2023) -
Motility phenotype in a zebrafish vmat2 mutant
por: Sveinsdóttir, Hildur Sóley, et al.
Publicado: (2022) -
Multi-parameter Behavioral Phenotyping of the MPP+ Model of Parkinson’s Disease in Zebrafish
por: Christensen, Christian, et al.
Publicado: (2020) -
Dynamics of Sleep–Wake Cyclicity at Night Across the Human Lifespan
por: Arnardóttir, Hrönn, et al.
Publicado: (2010) -
Strategies for genetic inactivation of long noncoding RNAs in zebrafish
por: Lavalou, Perrine, et al.
Publicado: (2019)